Democracy Dies in Darkness

How microdosing GLP-1 drugs became a longevity ‘craze’

Internet companies are helping stoke enthusiasm for “microdosing” weight-loss drugs for wellness, mood and joint pain.

8 min
(Washington Post illustration; iStock)

As a 62-year-old grandmother in Maine, Christine Babb doesn’t identify with the biohacker bros who try experimental medications to optimize their health. But after side effects from her first dose of a weight-loss drug hit her “like a Mack truck,” she, too, decided to experiment.

Subscribe for unlimited access to The Post
Save on unmatched reporting.
Get your first year for $20 USD
Already a subscriber? Sign in
LIMITED TIME OFFER

Last call for end of season savings

Get your first year of The Post for just 50¢ a week.
  • Unlimited access on the web and in our apps
  • 24/7 live news updates
One week
$5 USD
one-time payment
Monthly
50¢ USD
every week
Yearly
$20 USD
for the first year
Monthly billed as $2 USD every 4 weeks for first year.
Cancel anytime.
Add your email address
paypal
Card
View more offers